Patients with genetic variants affecting iron absorption, B12 utilization, or metabolic rate may experience more pronounced energy dips
The structure of oxidized OsDHAR was solved and refined using similar protocols
A monitoring protocol should also take into account the risks of hepatotoxicity, hyperuricemia, hypomagnesemia, hematologic abnormalities and malignancies, especially skin cancer and lymphomas
Frequent glucose monitoring and dosage adjustment may be necessary for LANTUS in patients with hepatic impairment [see Warnings and Precautions (5.3)]
There is also no KLOW trial that establishes the long-term safety of either schedule
However, it is not meant for the treatment of type 1 diabetes or diabetic ketoacidosis in adults